IMMUNOCORP CONSUMER HEALTH AS
Operating
Markedsføre og selge vitenskapelig dokumenterte kosttilskudd, og
dermed tilknyttet virksomhet.
Links
Organization
- CEO
- Chairman of the board
- Years since formation
- 26 years
- since Mar 9, 2000
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 800,000
- 1 share class
- Total number of shareholders
- 2
- companies
Financials
- Annual total result 2025
- 310,551
- NOK
- Total equity 2025
- 1,000,000
- NOK
Last update: Jul 7, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
| Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
| Chairman | - | |
| Board Member | - | |
MB | Alternate Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
| - | 50 % indirectly | |
| - | 50 % indirectly |
Last update: Jul 2, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 400,000 | 50 % | |
| Ordinary shares | 400,000 | 50 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | 310,551 | 643,975 | 1,268,838 | 863,221 | 836,620 |
Total assets | 4,295,017 | 4,095,141 | 3,672,415 | 3,035,862 | 2,296,297 |
Total liabilities | 3,295,017 | 124,610 | 345,860 | 28,025 | 151,682 |
Total equity | 1,000,000 | 3,970,530 | 3,326,556 | 3,007,837 | 2,144,615 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 | 0 |
Total operating costs | 67,363 | 97,052 | 144,921 | -87,789 | 71,726 |
Operating result | -67,363 | -97,052 | -144,921 | 87,789 | -71,726 |
Financial income/costs | 377,914 | 853,311 | 1,487,877 | 775,432 | 941,717 |
Profit before tax | 310,551 | 756,259 | 1,342,955 | 863,221 | 869,990 |
Total tax & extraordinary income/cost | 0 | 112,284 | 74,117 | 0 | 33,370 |
Annual Total Result | 310,551 | 643,975 | 1,268,838 | 863,221 | 836,620 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 4,080,549 | 4,080,549 | 3,538,936 | 2,731,360 | 1,500,085 |
Total current assets | 214,468 | 14,592 | 133,479 | 304,501 | 796,212 |
Total assets | 4,295,017 | 4,095,141 | 3,672,415 | 3,035,862 | 2,296,297 |
Short term debt | 3,295,017 | 124,610 | 345,860 | 28,025 | 151,682 |
Long term debt | 0 | 0 | 0 | 0 | 0 |
Total liabilities | 3,295,017 | 124,610 | 345,860 | 28,025 | 151,682 |
Contributed capital | 1,000,000 | 1,426,307 | 1,426,307 | 1,426,307 | 1,426,307 |
Retained earnings | 0 | 2,544,224 | 1,900,249 | 1,581,530 | 718,308 |
Total equity | 1,000,000 | 3,970,530 | 3,326,556 | 3,007,837 | 2,144,615 |
Total equity and liabilities | 4,295,017 | 4,095,141 | 3,672,415 | 3,035,862 | 2,296,297 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises